Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AAA-603 by Advanced Accelerator Applications for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Human Epidermal Growth Factor Receptor...
AAA-603 by Advanced Accelerator Applications for Metastatic Prostate Cancer: Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Metastatic Prostate Cancer. According to...
AAA-603 by Advanced Accelerator Applications for Esophageal Cancer: Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Esophageal Cancer. According to GlobalData,...
AAA-603 by Advanced Accelerator Applications for Neuroblastoma: Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Neuroblastoma. According to GlobalData, Phase...
AAA-603 by Advanced Accelerator Applications for Glioblastoma Multiforme (GBM): Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Glioblastoma Multiforme (GBM). According to...
AAA-603 by Advanced Accelerator Applications for Gastrointestinal Stromal Tumor (GIST): Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Gastrointestinal Stromal Tumor (GIST). According...
AAA-603 by Advanced Accelerator Applications for Head And Neck Cancer: Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Head And Neck Cancer. According...
AAA-603 by Advanced Accelerator Applications for Ovarian Cancer: Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Ovarian Cancer. According to GlobalData,...
AAA-603 by Advanced Accelerator Applications for Lung Cancer: Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase II for Lung Cancer. According to GlobalData,...
AAA-603 by Advanced Accelerator Applications for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
AAA-603 is under clinical development by Advanced Accelerator Applications and currently in Phase I for Recurrent Glioblastoma Multiforme (GBM). According...